126 related articles for article (PubMed ID: 30439415)
1. Effects of anti-estrogens on cell invasion and survival in pituitary adenoma cells: A systematic study.
Hannen R; Steffani M; Voellger B; Carl B; Wang J; Bartsch JW; Nimsky C
J Steroid Biochem Mol Biol; 2019 Mar; 187():88-96. PubMed ID: 30439415
[TBL] [Abstract][Full Text] [Related]
2. Selective estrogen receptor modulators decrease invasiveness in pituitary adenoma cell lines AtT-20 and TtT/GF by affecting expression of MMP-14 and ADAM12.
Zhang Z; Bartsch JW; Benzel J; Lei T; Nimsky C; Voellger B
FEBS Open Bio; 2020 Nov; 10(11):2489-2498. PubMed ID: 33030286
[TBL] [Abstract][Full Text] [Related]
3. ESR1 and its antagonist fulvestrant in pituitary adenomas.
Gao H; Xue Y; Cao L; Liu Q; Liu C; Shan X; Wang H; Gu Y; Zhang Y
Mol Cell Endocrinol; 2017 Mar; 443():32-41. PubMed ID: 28043824
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
Wang J; Zhang Z; Li R; Sun W; Chen J; Zhang H; Shu K; Lei T
Life Sci; 2018 Feb; 194():150-156. PubMed ID: 29288766
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor antagonist fulvestrant inhibits proliferation and promotes apoptosis of prolactinoma cells by regulating the IRE1/XBP1 signaling pathway.
Wang C; Bai M; Wang X; Tan C; Zhang D; Chang L; Li G; Xie L; Su J; Wen Y
Mol Med Rep; 2018 Oct; 18(4):4037-4041. PubMed ID: 30106152
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells.
Voellger B; Waldt N; Rupa R; Kirches E; Melhem O; Ochel HJ; Mawrin C; Firsching R
J Neurooncol; 2018 Sep; 139(3):573-582. PubMed ID: 29872948
[TBL] [Abstract][Full Text] [Related]
7. Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
Pituitary; 2014 Jun; 17(3):203-9. PubMed ID: 23649927
[TBL] [Abstract][Full Text] [Related]
8. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
Li Q; Su Z; Liu J; Cai L; Lu J; Lin S; Xiong Z; Li W; Zheng W; Wu J; Zhuge Q; Wu Z
Mol Cell Endocrinol; 2014 Jan; 382(1):377-384. PubMed ID: 24184771
[TBL] [Abstract][Full Text] [Related]
10. CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation.
Xu Y; Wang Y; Ma G; Wang Q; Wei G
J Neurooncol; 2014 Feb; 116(3):625-32. PubMed ID: 24420924
[TBL] [Abstract][Full Text] [Related]
11. AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.
Yurekli BS; Karaca B; Kisim A; Bozkurt E; Atmaca H; Cetinkalp S; Ozgen G; Yilmaz C; Uzunoglu S; Uslu R; Saygili F
J Endocrinol Invest; 2018 Feb; 41(2):233-240. PubMed ID: 28730425
[TBL] [Abstract][Full Text] [Related]
12. Common tools for pituitary adenomas research: cell lines and primary cells.
Zhu Z; Cui W; Zhu D; Gao N; Zhu Y
Pituitary; 2020 Apr; 23(2):182-188. PubMed ID: 31728905
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative, antiinvasive, and proapoptotic activity of folate receptor α-targeted liposomal doxorubicin in nonfunctional pituitary adenoma cells.
Liu X; Ma S; Dai C; Cai F; Yao Y; Yang Y; Feng M; Deng K; Li G; Ma W; Xin B; Lian W; Xiang G; Zhang B; Wang R
Endocrinology; 2013 Apr; 154(4):1414-23. PubMed ID: 23462961
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.
Lohrer P; Gloddek J; Hopfner U; Losa M; Uhl E; Pagotto U; Stalla GK; Renner U
Neuroendocrinology; 2001 Aug; 74(2):95-105. PubMed ID: 11474217
[TBL] [Abstract][Full Text] [Related]
16. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
Peano BJ; Crabtree JS; Komm BS; Winneker RC; Harris HA
Endocrinology; 2009 Apr; 150(4):1897-903. PubMed ID: 19022889
[TBL] [Abstract][Full Text] [Related]
17. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
18. Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.
Li W; Zhang Y; Zhang M; Huang G; Zhang Q
J Clin Neurosci; 2014 Jan; 21(1):137-41. PubMed ID: 24200887
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas.
Shan B; Schaaf C; Schmidt A; Lucia K; Buchfelder M; Losa M; Kuhlen D; Kreutzer J; Perone MJ; Arzt E; Stalla GK; Renner U
J Endocrinol; 2012 Sep; 214(3):389-98. PubMed ID: 22739211
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice.
Dai C; Zhang B; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wang J; Guo K; Ma W; Xing B; Lian W; Xiao J; Cai F; Zhang H; Wang R
Endocrinology; 2013 Mar; 154(3):1247-59. PubMed ID: 23384836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
